Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS46001058BKPyvENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS46001458BKPyvENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS10018710HBVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS30010291HIVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS30017984HIVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS30034815HIVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS30034816HIVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS30034817HIVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS30034818HIVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS30034819HIVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TCGA Plot Options
Drug Information
GeneFLT1
DrugBank IDDB04879
Drug NameVatalanib
Target IDBE0000029
UniProt IDP17948
Regulation Type
PubMed IDs17584317
CitationsYamamoto A, Watanabe H, Sueki H, Nakanishi T, Yasuhara H, Iijima M: Vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK 222584 inhibits both the induction and elicitation phases of contact hypersensitivity. J Dermatol. 2007 Jul;34(7):419-29.
GroupsInvestigational
Direct ClassificationPhthalazines
SMILESClC1=CC=C(NC2=NN=C(CC3=CC=NC=C3)C3=CC=CC=C23)C=C1
PathwaysVatalanib Action Pathway
PharmGKBPA7001
ChEMBLCHEMBL101253